Ann: Q2 FY25 Quarterly Investor Presentation & Webinar, page-3

The money shot for me in the presentation is slide 7 which gives a quarter by quarter breakdown of revenue.

It shows that they recovered somewhat in the December quarter from the disastrous September quarter when for whatever real reason the wheels almost fell off (and they came up with the silliest excuse I've heard from a listed company: the sharp drop in revenue for the September quarter was due to there being school holidays during that period, FMD!). But the December quarter revenue is still below the June quarter revenue: not quite what you'd expect of a company with a product line that is about to go viral. So better but not good enough.

Worth remembering that sometime in October the company employed Eric Davis as Chief Growth Officer and Chris Saad as Chief Product Officer. As a rough rule of thumb you give new executives up to three months to work out what they need to do and another three or so months to start doing what they need to do. So I would not hold the relatively modest December quarter's revenue against the two newbies - that responsibility sits squarely with the CEO - but I would expect ED and CS as members of the executive team to start making noticeable contributions to how the company progresses from this current quarter onwards (the Microba team is small enough for both of them to be contributing across the full scope of the company's activities).



In the quarterly they say that the transition away from existing product lines is the reason for the revenue stumble - not so much school holidays - but that the "focus on MetaXplore is expected to translate into growth in H2 FY25 as adoption gains momentum". So I guess that means they expect to shoot the lights out with ramping revenue numbers from now on, yes?